Analysis: U.S. Move to Loosen Vaccine Patents will Draw Drug Companies to Bargain -Lawyers
Details
- Publish Date:
- May 7, 2021
- Author(s):
-
- Erman, Michael ,
- Brittain, Blake
- Source:
- Reuters
- Related Person(s):
Summary
“I think the end result that most players are looking for here is not IP waiver in particular, it’s expanded global access to the vaccines,”
Read More